Nigella sativa oil for prevention of chronic cyclosporine nephrotoxicity: An experimental model

American Journal of Nephrology

Volumn 28, Issue 3, 2008, Pages 517-522

  Uz, Ebru ^a,c   Bayrak, Omer ^a   Uz, Efkan ^b   Kaya, Arif ^a   Bayrak, Reyhan ^a   Uz, Burak ^a   Turgut, Faruk Hilmi ^a   Bavbek, Nuket ^a   Kanbay, Mehmet ^a   Akcay, Ali ^a  

^a FATIH UNIVERSITY MEDICAL SCHOOL   (Turkey)

^b SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c NONE   (Turkey)

Author keywords

Antioxidant action; CsA treated rats; Cyclosporine A; Malondialdehyde; Nephrotoxicity; Nigella sativa; Nitric oxide

Indexed keywords

CATALASE; CYCLOSPORIN A; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NIGELLA SATIVA OIL; NITRIC OXIDE; SUNFLOWER OIL; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; VEGETABLE OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLACK CUMIN; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HISTOLOGY; KIDNEY DYSPLASIA; LONG TERM CARE; MALE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZATION; RAT; RENAL PROTECTION;

ANIMALS; ANTIOXIDANTS; CYCLOSPORINE; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY DISEASES; MALE; OXIDANTS; PHYTOTHERAPY; PLANT EXTRACTS; PLANT OILS; RATS; RATS, WISTAR;

EID: 41849149978     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000114004     Document Type: Article

References (36)

1. Burits M, Bucar F: Antioxidant activity of Nigella sativa essential oil. Phytother Res 2000;14:323-328.
2. Ali BH, Blunden G: Pharmacological and toxicological properties of Nigella sativa. Phytother Res 2003;17:299-305.
3. El Daly ES: Protective effect of cysteine and vitamin E, Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in rats. J Pharm Bel 1998;53:87-95.
4. Badary OA, Nagi MN, Al-Shabanah OA, Al-Shawaf HA, Al-Sohaibani MO, Al-Bekairi AM: Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity. Can J Physiol Pharmacol 1997;75:1356-1361.
5. Ali BH: The effect of Nigella sativa oil on gentamicin nephrotoxicity in rats Am J Chin Med 2004;32:49-55.
6. Cohen DJ, Loertscher R, Rubin MF, Tilney NL, Carpenter CB, Strom TB: Cyclosporine: a new immunosuppressive agent for organ transplantation. Ann Intern Med 1984;101:667-682.
7. Andoh TF, Bennett WM: Chronic cyclosporine nephrotoxicity. Curr Opin Nephrol Hypertens 1998;7:265-270.
8. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
9. Sun Y, Oberley LW, Li Y: A simple method for clinical assay of superoxide dismutase. Clin Chem 1988;34:497-500.
10. Aebi H: Catalase; in Bergmeyer HU (ed): Methods of Enzymatic Analysis. New York, Academic Press, 1974, pp 673-677.
11. Paglia DE, Valentine WN: Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-170.
12. Esterbauer H, Cheeseman KH: Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal; in Packer L, Glazer AN (eds): Oxygen Radicals in Biological Systems. Methods in Enzymology. San Diego, Academic Press, 1990, pp 407-421.
13. Cortas NK, Wakid NW: Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990;36:1440-1443.
14. Li C, Yang CW, Kim WY, Jung JY, Cha JH, Kim YS, Kim J, Bennett WM, Bang BK: Reversibility of chronic cyclosporine nephropathy in rats after withdrawal of cyclosporine. Am J Physiol Renal Physiol 2003;284:389-398.
15. Kang DH, Kim YG, Andoh TF, Gordon KL, Suga S, Mazzali M, Jefferson JA, Hughes J, Bennett W, Schreiner GF, Johnson RJ: Postcyclosporine-mediated hypertension and nephropathy: Amelioration by vascular endothelial growth factor. Am J Physiol Renal Physiol 2001;280:727-736.
16. Pichler RH, Franceschini N, Joung BA, Hugo C, Andoh TF, Burdmann EA, Shankland SJ, Alpers CE, Bennett WM, Couser WG: Pathogenesis of cyclosporine nephropathy: Roles of angiotensin II and osteopontin. J Am Soc Nephrol 1995;6:1186-1196.
17. Walker RJ, Lazzaro VA, Duggin GG, Horvath JS, Tiller DJ: Evidence that alterations in renal metabolism and lipid peroxidation may contribute to cyclosporine nephrotoxicity. Transplantation 1990;50:487-492.
18. Vardi N, Parlakpinar H, Ozturk F, Acet A: Gentamicin-induced nephrotoxicity and protective effect of caffeic acid phenethyl ester in rats. Fundam Clin Pharmacol 2005;19:173-177.
19. Yildirim Z, Sogut S, Odaci E, Iraz M, Ozyurt H, Kotuk M, Akyol O: Oral erdosteine administration attenuates cisplatin-induced renal tubular damage in rats. Pharmacol Res 2003;47:149-156.
20. Ateşşahin A, Ceribaşi AO, Yilmaz S: Lycopene, a carotenoid, attenuates cyclosporine-induced renal dysfunction and oxidative stress in rats. Basic Clin Pharmacol Toxicol 2007;100:372-376.
21. Parra T, De Arriba G, Arribas I, Perez de Lema G, Rodriguez-Puyol D, Rodriguez-Puyol M: Cyclosporine A nephrotoxicity: role of thromboxane and reactive oxygen species. J Lab Clin Med 1998;131:63-70.
22. Mohamadin AM, El-Beshbishy HA, El-Mahdy MA: Green tea extract attenuates cyclosporine A-induced oxidative stress in rats. Pharmacol Res 2005;51:51-57.
23. Durak I, Karabacak HI, Buyukkocak S, Cimen MY, Kacmaz M, Omeroglu E, Ozturk HS: Impaired antioxidant defense system in the kidney tissues from rabbits treated with cyclosporine. Protective effects of vitamins E and C. Nephron 1998;78:207-211.
24. Sabry A, El-Husseini A, Sheashaa H, Abdel-Shafy E, El-Dahshan K, Abdel-Rahim M, Abdel-Kaleek E, Abo-Zena H: Colchicine vs. omega-3 fatty acids for prevention of chronic cyclosporine nephrotoxicity in Sprague-Dawley rats: an experimental animal model. Arch Med Res 2006;37:933-940.
25. El Daly ES: Protective effect of cysteine and vitamin E, Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in rats. J Pharm Bel 1998;53:87-95.
26. Nagi MN, Alam K, Badary OA, al-Shabanah OA, al-Sawaf HA, al-Bekairi AM: Thymoquinone protects against carbon tetrachloride hepatotoxicity in mice via an antioxidant mechanism. Biochem Mol Biol Int 1999;47:153-159.
27. Turkdogan MK, Agaoglu Z, Yener Z, Sekeroglu R, Akkan HA, Avci ME: The role of antioxidant vitamins (C and E), selenium and Nigella sativa in the prevention of liver fibrosis and cirrhosis in rabbits, new hopes. Dtsch Tierärztl Wochenschr 2000;108:71-73.
28. Inselmann G, Hannemann J, Baumann K: Cyclosporine A induced lipid peroxidation and influence on glucose-6-phosphatase in rat hepatic and renal microsomes. Res Commun Chem Pathol Pharmacol 1990;68:189-203.
29. Suleymanlar G, Suleymanlar I, Shapiro JI, Chan L: Possible role of lipid peroxidation in cyclosporine nephrotoxicity in rats. Transplant Proc 1994;26:2888-2889.
30. Walker RJ, Lazzaro VA, Duggin GG, Horvath JS, Tiller DJ: Evidence that alterations in renal metabolism and lipid peroxidation may contribute to cyclosporine nephrotoxicity. Transplantation 1990;50:487-492.
31. Bobadilla NA, Gamba G, Tapia E, Garcia-Torres R, Bolio A, Lopez-Zetina P, Herrera-Acosta J: Role of NO in cyclosporin nephrotoxicity: effects of chronic NO inhibition and NO synthases gene expression. Am J Physiol 1998;274:791-798.
32. Mihatsch MJ, Kyo M, Morozumi K, Yamaguchi Y, Nickeleit V, Ryffel B: The side effects of cyclosporine A and tacrolimus. Clin Nephrol 1998;49:356-363.
33. Mihatsch MJ, Ryffel B, Gudat F: The differential diagnosis between rejection and cyclosporine toxicity. Kidney Int Suppl 1995;63-69.
34. Myers BD, Ross J, Newton L, Luetscher J, Perlroth M: Cyclosporine- associated chronic nephropathy. N Engl J Med 1984;311:699-705.
35. Vieira JM Jr, Noronha IL, Malheiros DM, Burdmann EA: Cyclosporine-induced interstitial fibrosis and arteriolar TGF-beta expression with preserved renal blood flow. Transplantation 1999;68:1746-1753.
36. Whiting PH, Thompson AW, Blair JT, Simpson JG: Experimental cyclosporin A nephrotoxicity. Br J Exp Pathol 1982;63:88-94.